UNSPSC 51281620: Paromomycin

This classification denotes an aminoglycoside antibiotic with the molecular formula C23H45N5O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 61JJC8N5ZK, chemically known as streptamine, o-2,6-diamino-2,6-dideoxy-beta-l-idopyranosyl-(1-3)-o-beta-d-ribofuranosyl-(1-5)-o-(2-amino-2-deoxy-alpha-d-glucopyranosyl-(1-4))-2-deoxy- but generally known as paromomycin, which bears US NIH Compound Identifier 24176.

UNSPSC 51281620 Paromomycin is a Commodity code that encompasses pharmaceutical procurement by state and local health agencies, though the recent solicitations tagged under this code show significant scope divergence — the opportunities actually being bought are naloxone, medical and first aid supplies, generic pharmaceuticals, and OTC products, not paromomycin specifically. State and local health departments, municipal fire departments, and cooperative purchasing alliances are the primary issuing bodies. The work involves procurement of finished pharmaceutical products and medical supplies through competitive bidding (IFB), requests for proposals (RFP), and requests for information (RFI) mechanisms. Vendors must typically meet federal compliance requirements such as cGMP certification, Drug Supply Chain Security Act (DSCSA) compliance, FDA approval, and E-Verify eligibility. Contracts often include multi-year terms with renewal options, quarterly or on-demand delivery schedules, firm pricing requirements, and mandatory insurance coverage including workers' compensation and commercial general liability.

Recent activity spans Florida, Texas, and Minnesota through cooperative purchasing structures. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026. The City of Tampa issued IFB 26P00145 in March 2026 for medical and first aid supplies totaling an estimated $700,000 for the Tampa Fire Department Rescue Division, with set-aside designation for certified Small Local Business Enterprises and a 5 percent SLBE bid discount. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline and July 1, 2026 contract effective date, serving multiple state and local facilities across participating jurisdictions including Oregon.